-

About

Ben leads the Genito-Urinary (GU) research program within the Gibbs Lab at WEHI. His team focuses on generating Real World Evidence (RWE) to change practice in GU cancers.

Ben is also a medical oncologist at Peter MacCallum Cancer Centre where he leads the GU medical oncology group and trials program. He is an Associate Professor at the University of Melbourne. Ben also chairs the Phase 1 Trials Group within Cancer Trials Australia and the Germ Cell Tumour group within ANZUP.

At WEHI, Ben leads multi-national registries in Prostate cancer, Urothelial cancer, Testis cancer and Kidney cancer. Data from these registries have been utilized to describe treatment patterns, identify clinical and tissue-based biomarkers and inform future research strategies. Ben has expanded the out-reach of these registries to Asia, with sites now contributing from Singapore and Korea. Ben is recognized globally for his leadership in RWE in GU cancers. Ben is also internationally recognized as an expert in testicular cancer, utilizing his RWE leadership to drive pragmatic clinical trials aimed at improving long term outcomes for testicular cancer survivors.

Ben also leads the early development of novel therapeutics in GU cancers. He is globally respected for his knowledge and expertise in early phase, first time in human clinical trials. His role within developmental therapeutics is essential in connecting scientists to clinicians and facilitating a bench to bedside and back to bench approach to cancer research.

Publications

Selected publications from Prof Ben Tran

Chow KVC, Conduit C, O’Haire S, Kuchel A, Wong S, Grimison P, Weickhardt A, Pranavan G, Lynam J, Bastick P, Goh J, Sengupta S, Smith A, Liow E, Campbell D, Wong M, Zlatic K, Gibbs P, Tran B, Gan CL. Extracranial, Extragonadal Germ Cell Tumors: A Multicenter Australian Case Series. Asia-Pacific Journal of Clinical Oncology. 2026;22(3):10.1111/ajco.70083

Pan HY, Mulholland CJ, Shi W, Furrer MA, Mizrahi GR, Conduit C, Tran B, Lawrentschuk N, Thomas BC. IP13-16 ROBOTIC-ASSISTED RETROPERITONEAL LYMPH NODE DISSECTION FOR METASTATIC TESTICULAR MALIGNANCIES – A 9-YEAR COMPARATIVE ANALYSIS OF THE OUTCOMES AND LEARNING CURVE. Journal of Urology. 2026;215(5S):10.1097/01.ju.0001191348.53260.b7.16

Panasci J, Park CL, Tran B, Siu LL. Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours. British Journal of Cancer. 2026;:10.1038/s41416-026-03450-w

Sherry AD, To V, D’souza C, Kiany S, Thio N, Liu S, Sun X, Castle B, Macdonald S, Choi H, Seo A, Hara K, Pryor D, Azad A, Tran B, Au L, Spain L, Ludmir EB, Jonasch E, Tannir NM, Msaouel P, Neeson P, Haymaker C, Tang C, Siva S. Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials. European Urology. 2026;:10.1016/j.eururo.2026.03.024

Lucas H, Dittmer B, Stapleton P, Tran B, Corcoran NM, Sathianathen N. Artificial Intelligence Chatbots as Information Sources on Testicular Cancer: Quality, Readability and Actionability. Société Internationale d’Urologie Journal. 2026;7(2):10.3390/siuj7020027

Pan HYC, Homewood D, Lucas H, Dittmer B, Teh J, O’Brien JS, Liu J, Tran B, Chee J, Churchill JA, Lawrentschuk N, Corcoran NM. The Australian Penile Cancer Clinical Registry: a comprehensive national approach to data collection. BJU International. 2026;:10.1111/bju.70188

Catto JWF, Daneshmand S, Zaucha R, Tran B, Master V, Lotan Y, Pignot G, Tubaro A, Shimizu N, Vasdev N, Lee EK, Procopio G, Galanternik F, Fischer DS, Levin TG, Zhang J, Thomas S, Stone N, Triantos S, Beeharry N. A0591 Longitudinal assessment of urine tumor DNA in high-risk non-muscle invasive bladder cancer patients. European Urology. 2026;89:10.1016/s0302-2838(26)00642-1

Harris W, Shirley S, Liow E, Tan A, Jacobs C, Fong P, Fu S, Tan E, Waldron N, Weickhardt A, Wong S, Tran B, Lawrence N. Real-World Outcomes in Advanced Clear Cell Renal Cell Carcinoma: A Retrospective Analysis Comparing New Zealand and Australian Cohorts. JCO Global Oncology. 2026;12(3):10.1200/go-25-00384

Anton A, Steer C, Arasaratnam M, Torres J, Weickhardt A, Warren M, Mislang ARA, Azad AA, Linton A, Smith A, Rai S, Hong W, Gibbs P, Tran B. Registry-based randomised phase II study of Enzalutamide versus Abiraterone: assessing cognitive function in eLderly patients with metastatic castration-resistant Prostate cancer (REAL-Pro). ESMO Real World Data and Digital Oncology. 2026;11:10.1016/j.esmorw.2025.100677

Pan HY-C, Shi W, Mulholland C, Conduit C, Tran B, Hitchen N, Lawrentschuk N, Thomas B. Primary retroperitoneal lymph node dissection for clinical stage IIA/B metastatic seminoma: A multi-centre Australian experience.Journal of Clinical Oncology. 2026;44(7_suppl):10.1200/jco.2026.44.7_suppl.601

Interested in supporting our research?

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Contact our friendly team to find out how you can help.

"*" indicates required fields